Clinical Trials

RenovoRx reports first RenovoCath procedure in post-marketing study

RenovoRx (Nasdaq: RNXT) this week said its RenovoCath drug-delivery device was used for the first time in its post-marketing registry study. The case was performed...

Medtronic Hugo surgical robot meets endpoints in hernia repair study

Medtronic announced that a study of its Hugo surgical robot met primary safety and effectiveness endpoints. Results came from the company’s Enable Hernia Repair clinical...

Peytant reports positive tracheobronchial covered stent results

Peytant Solutions announced positive pre-clinical outcomes for its AMStent tracheobronchial covered stent system. Dr. Roy Joseph Cho of the University of Minnesota presented the outcomes...

Stimvia reports positive outcomes with neuromodulation for Parkinson’s

Stimvia announced it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) technology. The Czech Republic-based company delivers peroneal eTNM through its...

Simpson Interventions reports first patient treated with Acolyte catheter

Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system. The Acolyte study, a pivotal investigational device...

Fractyl reports positive 2-year Revita results, prices $20m offering

Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

InterVene’s thrombectomy catheter showed success in first-in-human case

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The...

Xvivo enrolls first patient in Heart Assist Transport device study

Xvivo announced it enrolled the first patient as part of a continued access protocol (CAP) study for its Heart Assist Transport system. The CAP study...

Xeltis reports positive EU trial results for Xabg coronary bypass conduit

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...
1...456...58Page 5 of 58

Latest articles